Type II Diabetes in Young Pregnant and Non-Pregnant Women
1. Clinical Context Before Notelovitz’s Work
Before the 1970s–1980s:
Type II diabetes was viewed almost exclusively as a disease of older adults
Young women with hyperglycemia were often:
Misclassified as Type I diabetics
Or labeled as having only gestational diabetes
The metabolic risks of young, non-pregnant, insulin-resistant women were poorlyrecognized
Pregnancy outcomes in young women with early Type II diabetic physiology wereoften poorly predicted and poorly managed
2. Notelovitz’s Key Contributions
A. Recognition of Type II Diabetes in Young Women
Notelovitz helped establish that:
Type II diabetes can occur in adolescents and young adults, including:
Non-obese women
Women with subtle insulin resistance
Many women previously labeled as “gestational diabetics” actually had:
Underlying early Type II diabetes
Or pre-diabetic metabolic syndrome
This shifted clinical thinking away from age-restricted models of diabetes.
B. Differentiation Between:
True Gestational Diabetes (GDM)vs
Pre-existing Type II Diabetes unmasked by pregnancy
Notelovitz emphasized that:
Pregnancy acts as a physiologic “stress test” for insulin resistance
Women who fail this test early or severely often have:
Undiagnosed Type II diabetes
Or significant pre-diabetic insulin resistance
This distinction was critical because:

C. Focus on Young Pregnant Women With Type II Physiology
His work showed that young pregnant women with Type II diabetes had:
Higher rates of:
Macrosomia
Preeclampsia
Shoulder dystocia
Neonatal hypoglycemia
Worse outcomes when:
Mismanaged as Type I
Or undertreated as “mild GDM”
He promoted:
Aggressive metabolic control
Early insulin therapy when oral control failed
Close fetal growth surveillance
D. Young Non-Pregnant Women With Early Type II Diabetes
Notelovitz highlighted that young non-pregnant Type II diabetics frequently had:
Polycystic ovary syndrome–like physiology
Hyperinsulinemia even before hyperglycemia
Increased risk for:
Infertility
Early cardiovascular disease
Later pregnancy complications
This helped link:
Reproductive endocrinology + early metabolic disease
Decades before the concept of reproductive-metabolic syndrome became widespread.
3. Impact on Modern Clinical Practice
Notelovitz’s work contributed to:
Routine postpartum glucose testing after GDM
Recognition that:
Many “gestational diabetics” are actually early Type II diabetics
Earlier lifestyle and pharmacologic intervention in young women
Integration of:
Obstetrics
Endocrinology
Preventive cardiometabolic medicine
2. 3. 4.
These concepts are now embedded in:
ACOG
ADA
Endocrine Society guidelines
4. Conceptual Advances Linked to His Work
Notelovitz helped advance the idea that:
Type II diabetes begins decades before diagnosis
Pregnancy is:
A metabolic unmasking event
Young women with glucose intolerance are a high-risk cardiometabolic population,not a temporary obstetric issue
5. Historical Significance
His contributions were particularly important because they:
Bridged:
Obstetrics
Reproductive endocrinology
Preventive diabetology
Shifted diabetes thinking from:
“An older person’s disease” to “A life-course metabolic disorder beginning in youth”
